Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.49 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 3/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.38 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | HTR1D | P28221 | 1/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL27984668 | 0.92 | CA2 (0.44) | CA2SSTR4HTR1ASIGMAR1ADRA2A | |
| SCHEMBL4672085 | 0.83 | CA2 (0.49) | CA2SSTR4HTR1ASIGMAR1ADRA2A | |
| SCHEMBL6591026 | 0.83 | CA2 (0.56) | CA2SSTR4HTR1ASIGMAR1ADRA2A | |
| SCHEMBL11072331 | 0.82 | HPGD (0.43) | CA2NISCHMAOAMAOBHDAC3 | |
| Hydrochloric Acid SCHEMBL28080389 | 0.81 | AOC2 (0.42) | CA2NISCHMAOAMAOBHDAC3 | |
| SCHEMBL1365698 | 0.80 | CA2 (0.47) | CA2HTR1ASIGMAR1ADRA2AADRA2B | |
| SCHEMBL2985307 | 0.79 | ESR1 (0.55) | CA2CA1 | |
| SCHEMBL8650215 | 0.79 | CA2 (0.46) | CA2SSTR4HTR1ASIGMAR1ADRA2A | |
| SCHEMBL8650317 | 0.79 | CA2 (0.49) | CA2SSTR4HTR1ASIGMAR1ADRA2A | |
| Hydrochloric Acid SCHEMBL30887472 | 0.78 | ESR1 (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050124687-A1 | Process for synthesizing d-tocotrienols | COULADOUROS ELIAS A (GR) | 2005-06-09 | — | — | US | claimed |
| WO-2005035490-A2 | PROCESS FOR SYNTHESIZING d-TOCOTRIENOLS | YASOO HEALTH, INC. (US) | 2005-04-21 | — | — | WO | claimed |
| WO-2024144812-A1 | PROCESS FOR THE PREPARATION OF DELTA-TOCOTRIENOL | PEPTINOVO BIOPHARMA INC. (US) | 2024-07-04 | — | — | WO | disclosed |
| WO-2024145566-A1 | PROCESS FOR THE PREPARATION OF DELTA-TOCOTRIENOL | PEPTINOVO BIOPHARMA, INC (US) | 2024-07-04 | — | — | WO | disclosed |
| EP-4393913-A1 | PROCESS FOR THE PREPARATION OF DELTA-TOCOTRIENOL | Peptinovo Biopharma Inc. (US) | 2024-07-03 | — | — | EP | disclosed |
| CN-103596564-B | diphenylmethane derivatives as SGLT2 inhibitors | GREEN CROSS CORP. (KR) | 2016-05-04 | — | — | CN | disclosed |
| CN-104334535-A | Dendrimer-like aminoamides with sodium channel blocking activity for the treatment of dry eye and other mucosal diseases | PARION SCIENCES INC | 2015-02-04 | — | — | CN | disclosed |
| CN-103415504-A | 2-acyloxy-pyrrolin-4-ones | BAYER IP GMBH | 2013-11-27 | — | — | CN | disclosed |
| US-20050124687-A1 | Process for synthesizing d-tocotrienols | COULADOUROS ELIAS A (GR) | 2005-06-09 | — | — | US | disclosed |
| WO-2005035490-A2 | PROCESS FOR SYNTHESIZING d-TOCOTRIENOLS | YASOO HEALTH, INC. (US) | 2005-04-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050124687-A1 | Process for synthesizing d-tocotrienols | UGT8, DDOST, GGPS1 | CA2 4668/4885SSTR4 1760/4885HTR1A 3367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.